ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

GANX Gain Therapeutics Inc

2.85
-0.11 (-3.72%)
After Hours
Last Updated: 06:49:43
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Gain Therapeutics Inc GANX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.11 -3.72% 2.85 06:49:43
Open Price Low Price High Price Close Price Previous Close
2.99 2.82 3.025 2.85 2.96
more quote information »

Recent News

Date Time Source Heading
24/4/202423:25GLOBEGain Therapeutics Announces Positive Results from the Single..
08/4/202423:25GLOBEGain Therapeutics Bolsters Management Team with the..
02/4/202400:25GLOBEGain Therapeutics Strengthens Management Team and Appoints..
26/3/202423:00GLOBEGain Therapeutics Reports Financial Results for Year End..
16/3/202405:30GLOBEGain Therapeutics to Present at Public Ventures Discovery..
06/3/202400:00GLOBEGain Therapeutics Presents Data at the AD/PD™ 2024..
28/2/202406:00GLOBEGain Therapeutics Announces the Initiation of the Multiple..
22/2/202423:00EDGAR2Form 8-K - Current report
15/2/202404:29GLOBEGain Therapeutics Announces 2024 R&D Update on Parkinson’s..
07/2/202401:56GLOBEUPDATE - Gain Therapeutics’ GT-02287 Completely Restores..
07/2/202400:00GLOBEGain Therapeutics’ GT-02287 Completely Restores Motor..
01/2/202409:26EDGAR2Form 8-K - Current report
01/2/202400:00GLOBEGain Therapeutics’ CEO Matthias Alder Issues Letter to..
03/1/202408:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/1/202400:00GLOBEGain Therapeutics Announces Acceptance of Late-Breaking..
02/1/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
20/12/202308:52EDGAR2Form S-1 - General form for registration of securities under..
02/12/202300:00GLOBEGain Therapeutics Announces Preclinical Data Showing..
30/11/202300:00GLOBEGain Therapeutics to Participate in AI Driven Drug Discovery..
25/11/202305:01GLOBEGain Therapeutics Announces Closing of $10.1 Million Public..
24/11/202322:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/11/202309:27EDGAR2Form 8-K - Current report
22/11/202300:54GLOBEGain Therapeutics Announces Pricing of $9.4 Million Public..
21/11/202308:22EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/11/202308:03GLOBEGain Therapeutics Announces Proposed Public Offering
18/11/202308:27EDGAR2Form 8-K - Current report
15/11/202308:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/202308:02EDGAR2Form 8-K - Current report
14/11/202323:00GLOBEGain Therapeutics Announces Third Quarter 2023 Financial..
04/10/202322:00GLOBEGain Therapeutics Announces Dosing of First Two Subjects in..
26/9/202306:05GLOBEGain Therapeutics to Participate at Cantor Fitzgerald Global..
21/9/202306:05GLOBEGain Therapeutics to Present at the Cambridge Healthtech..
12/9/202323:25GLOBEGain Therapeutics Receives Approval to Commence Phase 1..
11/8/202306:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202306:02EDGAR2Form 8-K - Current report
10/8/202321:00GLOBEGain Therapeutics Announces Second Quarter 2023 Financial..
07/8/202321:00GLOBEGain Therapeutics Announces Acceptance of Late Breaking..
31/7/202322:00GLOBEGain Therapeutics to Participate in the 2023 BTIG Virtual..
01/6/202322:00GLOBEGain Therapeutics to Present at the Jefferies Healthcare..
12/5/202322:00GLOBEGain Therapeutics Reports First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock